TEVA
Stock Details
TEVA is Teva Pharmaceutical Industries Limited's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 8.55$. Average daily volumn in 3 months 11.97M. Market cap 8.49B
Stock symbol : TEVA. Exchange : NYSE. Currency : USD Lastest price : 7.45$. Total volume : 14.81M. Market state CLOSED Click reload if you want to check the lastest price on market!!!
Teva Pharmaceutical Industries Limited (TEVA)
Last Price
7.45$Change
0.12Volume
14.81M
| Previous Close | 7.33 |
| Open | 7.45 |
| Day Range | 7.33-7.50 |
| Bid | 7.45 x 21.5k |
| Ask | 7.49 x 4k |
| Volume | 14.81M |
| Average Volume | 11.97M |
| Market Cap | 8.49B |
| Beta | 1.19 |
| 52 Week Range | 6.78-11.45 |
| Trailing P/E | N/A |
| Foward P/E | 3.04 |
| Dividend (Yield %) | N/A |
| Ex-Dividend Date | 2017-11-27 |
Financial Details
Organization
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also manufactures and sells activ... e pharmaceutical ingredients, as well as provides contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. In addition, it focuses on the central nervous system (CNS), pain, respiratory, and oncology areas. The company's products portfolio in the CNS field comprises Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; and AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; respiratory therapeutic area includes ProAir RespiClick, QVAR, ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease; and oncology therapeutic field consists of Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Market Cap:
8.49BRevenue:
14.93BTotal Assets:
44.01BTotal Cash:
2.8B
News about "Teva Pharmaceutical Industries Limited"
Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Winner
Source from : TheStreet.com - 15 days ago
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, produces, and markets generic drugs; and proprietary branded pharmaceuticals in various therapeutic categories and ...See details»
Teva Pharmaceutical Industries Limited (TEVA) Q1 2023 Earnings Call Transcript
Source from : Seeking Alpha - 19 days ago
Hello, and welcome to the Q1 2023 Teva Pharmaceutical Industries Limited earnings conference call. My name is Alex. I'll be coordinating the call today. [Operator instructions]. I'll now hand over ...See details»
Why Is Teva Pharmaceutical Industries Limited (NYSE: TEVA) Gaining?
Source from : stocksregister - 22 days ago
Teva Pharmaceutical Industries Limited (NYSE:TEVA) traded at $9.00 at last check on Monday, May 08, made an upward move of 2.62% on its previous day’s price. Looking at the stock we see that its ...See details»
Teva Pharmaceutical Industries Limited (TEVA) Shares Down Despite Recent Market Volatility
Source from : newsheater - 2 month ago
Teva Pharmaceutical Industries Limited (NYSE: TEVA)’s stock price has gone decline by -1.69 in comparison to its previous close of 7.69, however, the company has experienced a -7.01% decrease in its ...See details»
Teva Pharmaceutical Industries Limited (TEVA) Shares Plummet Below 1-Year High
Source from : newsheater - 12 days ago
Teva Pharmaceutical Industries Limited (NYSE: TEVA)’s stock price has gone decline by 0.00 in comparison to its previous close of 8.13, however, the company has experienced a -2.63% decrease in its ...See details»
Teva Pharmaceutical Industries Limited’s (TEVA) Outlook: Recollecting The Past For Future Insights
Source from : stocksregister - 10 days ago
Teva Pharmaceutical Industries Limited (NYSE:TEVA) price on Thursday, May 18, rose 1.60% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $8.26. A look at ...See details»
Compared to Estimates, Teva Pharmaceutical Industries Ltd. (TEVA) Q1 Earnings: A Look at Key Metrics
Source from : Nasdaq - 19 days ago
For the quarter ended March 2023, Teva Pharmaceutical Industries Ltd. (TEVA) reported revenue of $3.66 billion, representing no change compared to the same period last year. EPS came in at $0.40 ...See details»
Teva Pharmaceutical Industries Limited Q1 Earnings Summary
Source from : Business Insider - 19 days ago
(RTTNews) - Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA): Earnings: -$205 million in Q1 vs. -$955 million in the same period last year. EPS: -$0.18 in Q1 vs.See details»
Teva Pharmaceutical Industries Ltd (TEVA) has risen 0.73% Thursday In Premarket Trading
Source from : Benzinga.com - 1 month ago
TEVA has an Overall Score of 53. Find out what this means to you and get the rest of the rankings on TEVA!See Full TEVA ReportTEVA stock closed at $8.21 and is Teva Pharmaceutical Industries Ltd ...See details»
Teva Pharmaceutical Industries Limited American Depositary Shares
Source from : TheStreet.com - 11 days ago
TEVA PHARMACEUTICALS's gross profit margin for the fourth quarter of its fiscal year 2022 has decreased when compared to the same period a year ago. Sales and net income have dropped, although the ...See details»
New Suit - Antitrust Class Action
Source from : Law - 10 days ago
Teva Pharmaceutical Industries and subsidiary Norton Ltd. were slapped with an antitrust class action on Friday in Massachusetts District Court. The suit, brought by Sperling & Slater and Berman ...See details»
Teva Pharmaceutical Industries Limited (0LER.L)
Source from : Yahoo Finance - 1 month ago
TEL AVIV, Israel & PARSIPPANY, N.J., May 20, 2023--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that four studies across its ...See details»
Teva Pharmaceutical Industries Ltd. ADR
Source from : Wall Street Journal - 1 year ago
No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...See details»
Teva Pharmaceutical Industries Ltd (TEV.SG)
Source from : Yahoo Finance - 1 month ago
U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced an expansion of medicine donations through their collaborative mental health access program into seven new ...See details»